EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target

Khanyisani Ziqubu iD, Sithandiwe E Mazibuko-Mbeje, Sinenhlanhla X H Mthembu iD, Sihle E Mabhida, Babalwa U Jack, Tawanda M Nyambuya iD, Bongani B Nkambule, Albertus K Basson, Luca Tiano iD, Phiwayinkosi V Dludla iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032227 ↗

Kurz gefasst

Scoping Review in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Khanyisani Ziqubu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa. Hauptthemen laut MEDLINE: Adipose Tissue, Brown, Metformin. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, National Research Foundation (NRF) Thuthuka Programme, North-West University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brown adipose tissue (BAT) is increasingly recognized as the major therapeutic target to promote energy expenditure and ameliorate diverse metabolic complications. There is a general interest in understanding the pleiotropic effects of metformin against metabolic complications. Major electronic databases and search engines such as PubMed/MEDLINE, Google Scholar, and the Cochrane library were used to retrieve and critically discuss evidence reporting on the impact of metformin on regulating BAT thermogenic activity to ameliorate complications linked with obesity. The summarized evidence suggests that metformin can reduce body weight, enhance insulin sensitivity, and improve glucose metabolism by promoting BAT thermogenic activity in preclinical models of obesity. Notably, this anti-diabetic agent can affect the expression of major thermogenic transcriptional factors such as uncoupling protein 1 (UCP1), nuclear respiratory factor 1 (NRF1), and peroxisome-proliferator-activated receptor gamma coactivator 1-alpha (PGC1-α) to improve BAT mitochondrial function and promote energy expenditure. Interestingly, vital molecular markers involved in glucose metabolism and energy regulation such as AMP-activated protein kinase (AMPK) and fibroblast growth factor 21 (FGF21) are similarly upregulated by metformin treatment in preclinical models of obesity. The current review also discusses the clinical relevance of BAT and thermogenesis as therapeutic targets. This review explored critical components including effective dosage and appropriate intervention period, consistent with the beneficial effects of metformin against obesity-associated complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose Tissue, BrownMetforminHumansFeasibility StudiesObesityGlucoseThermogenesisEnergy MetabolismUncoupling Protein 1Adipose Tissue, White

Stichwörter der Autor:innen

brown adipose tissuemetabolismmetforminobesitytherapeutic targetthermogenesis

Substanzen

MetforminGlucoseUncoupling Protein 1

Autor:innen und Institutionen

  • Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
  • Department of Biochemistry, North-West University, Mmabatho 2745, South Africa.
  • Department of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
  • Department of Health Sciences, Namibia University of Science and Technology, Windhoek 9000, Namibia.
  • School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
  • Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3880, South Africa.

ORCID-Profile: Khanyisani Ziqubu, Sinenhlanhla X H Mthembu, Tawanda M Nyambuya, Luca Tiano, Phiwayinkosi V Dludla

Förderung

  • National Research Foundation
  • National Research Foundation (NRF) Thuthuka Programme
  • North-West University
  • University of Zululand
  • South African Medical Research Council (SAMRC)

Zitieren

APA

Ziqubu, K., Mazibuko-Mbeje, S. E., Mthembu, S. X. H., Mabhida, S. E., Jack, B. U., Nyambuya, T. M., Nkambule, B. B., Basson, A. K., Tiano, L., & Dludla, P. V. (2023). Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032227

Vancouver

Ziqubu K, Mazibuko-Mbeje SE, Mthembu SXH, Mabhida SE, Jack BU, Nyambuya TM, et al. Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032227

BibTeX
@article{Ziqubu2023,
  author = {Ziqubu, Khanyisani and Mazibuko-Mbeje, Sithandiwe E and Mthembu, Sinenhlanhla X H and Mabhida, Sihle E and Jack, Babalwa U and Nyambuya, Tawanda M and Nkambule, Bongani B and Basson, Albertus K and Tiano, Luca and Dludla, Phiwayinkosi V},
  title = {Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032227}
}
Kostenlos starten →